Non-Small Cell Lung Cancer (NSCLC) Harboring EGFR Mutations (EGFR-m) and Breast Cancer (BC): A Retrospective Analysis

被引：0
|
作者：
Moran, Teresa [1 ]
Quiroga, Vanesa [1 ]
Carcereny, Enric [1 ]
Cirauqui, Beatriz [1 ]
Margeli, Mireia [1 ]
Vila, Laia [1 ]
De Los, Maria [1 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Med Oncol, Badalona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
EGFR mutations; Breast Cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI13.13
引用
收藏
页码：S310 / S311
页数：2
相关论文
共 50 条
  • [11] Prevalence of EGFR mutations in patients with Non-Small Cell Lung Cancer (NSCLC) in Turkish population
    Sener, E.
    Kosemehmetoglu, K.
    Tezel, G. Guler
    VIRCHOWS ARCHIV, 2013, 463 (02) : 320 - 320
  • [12] Assessment of EGFR mutations in patients diagnosed of squamous non-small cell lung cancer (NSCLC).
    Lobo, Francisco
    Domine, Manuel
    Rojo, Federico
    Izarzugaza, Yann
    Leon, Ana
    Casado, Victoria
    Jesus Fernandez-Acenero, Maria
    Rubio, Gustavo
    Ignacio Martin-Valades, Jose
    Luis Arranz, Juan
    Serrano, Gloria
    Carames, Cristina
    Cordova, Sharon
    Madoz, Juan
    Zazo, Sandra
    Rincon, Raul
    Canadas, Carmen
    Perez-Gonzalez, Nuria
    Campos, Angel
    Garcia-Foncillas, Jesus
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [13] EGFR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) AND CORRELATION WITH SENSITIVITY TO ERLOTINIB
    Ricciardi, S.
    Tedesco, B.
    Migliorino, M. R.
    Graziano, P.
    Leone, A.
    Di Salvia, M.
    Capodaglio, V.
    Condo, S.
    De Santis, S.
    De Marinis, F.
    EJC SUPPLEMENTS, 2008, 6 (14): : 134 - 134
  • [14] Prevalence of EGFR mutations in non-small cell lung cancer (NSCLC) smoker patients.
    Izarzugaza, Yann
    Domine, Manuel
    Rojo, Federico
    Casado, Victoria
    Leon, Ana
    Jesus Fernandez-Acenero, Maria
    Rubio, Gustavo
    Cordova, Sharon
    Madoz, Juan
    Ignacio Martin-Valades, Jose
    Luis Arranz, Juan
    Serrano, Gloria
    Carames, Cristina
    Zazo, Sandra
    Rincon, Raul
    Canadas, Carmen
    Perez-Gonzalez, Nuria
    Campos, Angel
    Lobo, Francisco
    Garcia-Foncillas, Jesus
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [15] POPULATION BASED STUDY OF THE PREVALENCE OF EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Skov, Birgit G.
    Hogdall, Estrid
    Clementsen, Paul
    Krasnik, Mark
    Larsen, Klaus R.
    Sorensen, Jens B.
    Mellemgaard, Anders
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1082 - S1083
  • [16] EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
    Xiuning Le
    Eric Nadler
    Daniel B. Costa
    John Victor Heymach
    Targeted Oncology, 2023, 18 : 807 - 817
  • [17] Outcomes of EGFR-TKIs for patients with non-small cell lung cancer harboring EGFR mutations with poor performance status
    Hashimoto, K.
    Okuma, Y.
    Hakozaki, T.
    Watanabe, K.
    Hosomi, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [18] Impact of EGFR-Tyrosine Kinase Inhibitors for Postoperative Recurrent Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Igawa, S.
    Sato, Y.
    Kusuhara, S.
    Harada, S.
    Shirasawa, M.
    Kurahayashi, S.
    Okuma, Y.
    Sugimoto, A.
    Sugita, K.
    Nakahara, Y.
    Otani, S.
    Fukui, T.
    Yokoba, M.
    Mitsufuji, H.
    Kubota, M.
    Katagiri, M.
    Sasaki, J.
    Masuda, N.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2126 - S2127
  • [19] Osimertinib in non-small cell lung cancer (NSCLC) with atypical EGFR activating mutations: A retrospective multicenter study.
    Ji, Jingran
    Aredo, Jacqueline, V
    Piper-Vallillo, Andrew
    Huppert, Laura
    Rotow, Julia K.
    Husain, Hatim
    Stewart, Susan L.
    Cobb, Rosemary
    Wakelee, Heather A.
    Blakely, Collin Michael
    Wong, Melisa L.
    Gubens, Matthew A.
    Chen, Justin
    Oxnard, Geoffrey R.
    McCoach, Caroline Elizabeth
    Piotrowska, Zofia
    Neal, Joel W.
    Riess, Jonathan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [20] EGFR mutation status of cell free serum DNA and clinical efficacy of afatinib in pretreated non-small cell lung cancer (NSCLC) harboring EGFR mutations.
    Kitazono, Satoru
    Nishizawa, Hironari
    Kobayashi, Hiroshi
    Oguri, Tomoyo
    Tambo, Yuichi
    Yanagitani, Noriko
    Horiike, Atsushi
    Ohyanagi, Fumiyoshi
    Horai, Takeshi
    Nishio, Makoto
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345